HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dauvilliers, Y Articles by Bassetti, C L Search for Related Content PubMed PubMed Citation Articles by Dauvilliers, Y Articles by Bassetti, C L Related Collections Sleep Apnea

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions

¹ Service de Neurologie B, Hôpital Gui-de-Chauliac, Montpellier, France
² Biochemistry and Genetics, Department of Psychiatry, Geneva, Switzerland
³ INSERM E0361, Hôpital la Colombière, Montpellier, France
⁴ Neurology Clinic, University Hospital Zurich, Switzerland
⁵ Service de Psychopathologie de l’Enfant et de l’Adolescent, Hôpital Robert Debré, Paris, France
⁶ Institute of Clinical Chemistry, University Hospital Zurich, Switzerland

Correspondence to:
Correspondence to:
Dr Yves Dauvilliers
Service de Neurologie B, Hôpital Gui-de-Chauliac, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France; ydauvilliers{at}yahoo.fr

Objective: To determine the role of CSF hypocretin-1 in narcolepsy with and without cataplexy, Kleine-Levin syndrome (KLS), idiopathic and other hypersomnias, and several neurological conditions.

Patients: 26 narcoleptic patients with cataplexy, 9 narcoleptic patients without cataplexy, 2 patients with abnormal REM-sleep-associated hypersomnia, 7 patients with idiopathic hypersomnia, 2 patients with post-traumatic hypersomnia, 4 patients with KLS, and 88 patients with other neurological disorders.

Results: 23 patients with narcolepsy-cataplexy had low CSF hypocretin-1 levels, while one patient had a normal hypocretin level (HLA-DQB1*0602 negative) and the other two had intermediate levels (familial forms). One narcoleptic patient without cataplexy had a low hypocretin level. One patient affected with post-traumatic hypersomnia had intermediate hypocretin levels. The KLS patients had normal hypocretin levels while asymptomatic, but one KLS patient (also affected with Prader-Willi syndrome) showed a twofold decrease in hypocretin levels during a symptomatic episode. Among the patients without hypersomnia, two patients with normal pressure hydrocephalus and one with unclear central vertigo had intermediate levels.

Conclusion: Low CSF hypocretin-1 is highly specific (99.1%) and sensitive (88.5%) for narcolepsy with cataplexy. Hypocretin ligand deficiency appears not to be the major cause for other hypersomnias, with a possible continuum in the pathophysiology of narcolepsy without cataplexy and idiopathic hypersomnia. However, partial hypocretin lesions without low CSF hypocretin-1 consequences cannot be definitely excluded in those disorders. The existence of normal hypocretin levels in narcoleptic patients and intermediate levels in other rare aetiologies needs further investigation, especially for KLS, to establish the functional significance of hypocretin neurotransmission alterations.

Keywords: Hypocretin; narcolepsy; hypersomnia; HLA; cataplexy; familial; Kleine-Levin; neurological disorders

Abbreviations: EDS, excessive daytime sleepiness; ICSD, international classification of sleep disorders; KLS, Kleine-Levin syndrome; MSLT, multiple sleep latency test; PLM, periodic leg movements; RDI, respiratory disturbances index; SOREMP, sleep onset REM period

This article has been cited by other articles:

				B Carlander, T Vincent, A Le Floch, N Pageot, W Camu, and Y Dauvilliers Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 333 - 334. [Full Text] [PDF]

				Y. Dauvilliers, B. Abril, M. Charif, P. Quittet, L. Bauchet, B. Carlander, and J. Touchon REVERSAL OF SYMPTOMATIC TUMORAL NARCOLEPSY, WITH NORMALIZATION OF CSF HYPOCRETIN LEVEL Neurology, September 18, 2007; 69(12): 1300 - 1301. [Full Text] [PDF]

				M. Moore, D. Allison, and C. L. Rosen A review of pediatric nonrespiratory sleep disorders. Chest, October 1, 2006; 130(4): 1252 - 1262. [Abstract] [Full Text] [PDF]

				T. J. Young and M. H. Silber Hypersomnias of central origin. Chest, September 1, 2006; 130(3): 913 - 920. [Abstract] [Full Text] [PDF]

				E. Mignot, L. Lin, L. Finn, C. Lopes, K. Pluff, M. L. Sundstrom, and T. Young Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults Brain, June 1, 2006; 129(6): 1609 - 1623. [Abstract] [Full Text] [PDF]

				C R Baumann, R Khatami, E Werth, and C L Bassetti Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 402 - 404. [Abstract] [Full Text] [PDF]

				I. Arnulf, J. M. Zeitzer, J. File, N. Farber, and E. Mignot Kleine-Levin syndrome: a systematic review of 186 cases in the literature Brain, December 1, 2005; 128(12): 2763 - 2776. [Abstract] [Full Text] [PDF]

				C. R. Baumann, R. Stocker, H. -G. Imhof, O. Trentz, M. Hersberger, E. Mignot, and C. L. Bassetti Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury Neurology, July 12, 2005; 65(1): 147 - 149. [Abstract] [Full Text] [PDF]

				Y. Dauvilliers, K. Cervena, B. Carlander, F. Espa, C. Bassetti, B. Claustrat, J. L. Laplanche, M. Billiard, and J. Touchon Dissociation in circadian rhythms in a pseudohypersomnia form of fatal familial insomnia Neurology, December 28, 2004; 63(12): 2416 - 2418. [Abstract] [Full Text] [PDF]